Journey through time - Imagery rescripting of distressing memories

Organizational Data

DRKS-ID:
DRKS00031495
Recruitment Status:
Recruiting ongoing
Date of registration in DRKS:
2023-04-05
Last update in DRKS:
2024-05-08
Registration type:
Prospective

Acronym/abbreviation of the study

Journey through time

URL of the study

No Entry

Brief summary in lay language

In the present study, imaginative techniques are carried out on patients with depression in four study sessions. The study therapy will take place in addition to the regular cognitive behavioral therapy of the patients. A total of 60 patients will be included in the study. The patients are randomly assigned two conditions: In one condition (ImRs, experimental condition), stressful childhood memories are positively changed with the help of trained study therapists using the technique of imagery rescripting in such a way that the emotional quality of the respective situation changes in a direction that is comfortable for the patient. In the other condition (guided imagery, control condition), the patients get an imaginative relaxation exercise guided by the study therapists.

Brief summary in scientific language

Cognitive Behavioural Therapy (CBT) for depression involves verbal restructuring of negative thoughts and/or behavioural activation (Beck, 1991). These therapeutic techniques target dysfunctions in the underlying Cognitive and Behavioural aspects of depression. The fact that many patients with depression do not improve in treatment (Cuijpers et al., 2021) suggests that current treatments do not sufficiently target key-clinical features of depression. Recent innovations in psychotherapy research have stressed the importance of eliciting and transforming emotions in addition to cognitions and behavior (Greenberg, 2004, 2010). Experimental research has shown that mental imagery processing has a greater impact on emotion than verbal processing (Holmes, Deeprose, Geddes, & Goodwin, 2009; Holmes, Geddes, Colom, & Goodwin, 2008). Thus, one way to target emotional processing in depression might be via mental imagery. Imagery Rescripting (ImRs) is a therapeutic technique that targets distressing memories by imagining the distressing memory as vividly as possible in a first step and by imaging the sequence of events in a more desirable direction fulfilling emotional needs in a second step (Arntz, 2020; Arntz & Weertman, 1999). The aim of this procedure is to take the edge of the emotional impact of the memory by changing the (emotional) meaning of the memory representation. As the majority of depressed patients report to experience distressing memories and as depression is linked to adverse childhood experiences, the aim of this study is to investigate whether ImRs has an effect on depressive symptom severity during standard CBT for depression. In a randomized-controlled trial, 60 patients with a depressive disorder will be assigned to one of two conditions: 1. ImRs (Imagery Rescripting - experimental condition) or 2. Guided Imagery (control condition). After a baseline measurement, three intervention sessions will take place. The sessions will take place at the Institute of Psychology - Department of Clinical Psychology and Psychotherapy, University of Freiburg. The sessions will be followed by follow-up measurements (online) at intervals of one and four weeks and 2 months after the last session.

Health condition or problem studied

ICD10:
F32 - Depressive episode
ICD10:
F33 - Recurrent depressive disorder
ICD10:
F34.1 - Dysthymia
Healthy volunteers:
No

Interventions, Observational Groups

Arm 1:
Imagery rescripting of distressing memories
Arm 2:
Guided imagery relaxation

Endpoints

Primary outcome:
Scores on the Beck Depression Inventory-II (BDI-II; Beck, Steer & Brown, 1996) before randomization (baseline), one week after the last session (post-treatment) and at 4 weeks and 2 month after the last session (follow-up).
Secondary outcome:
1. Depressive symptom severity, measured by PHQ-9, at every measurement: Before randomization (baseline), just prior to every session, one week after the last study therapy (post-treatment) and 4 weeks and 2 months after the last session (follow-up) 2. Repetitive negative thinking measured by the Perserverative Thinking Questionnaire (PTQ; Ehring et al., 2011): Before randomization (baseline), one week after the last study therapy (post-treatment) and 4 weeks and 2 months after the last session (follow-up) 3. Scores on the German questionnaire SEK-27 (Self-Assessment of Emotional cababilities) before randomization (baseline), one week after the last session (post-treatment) and 4 weeks and 2 months after the last session (follow-up) 4. Scores on the short version of the German version of the Self-Compassion Scale (SCS-SV; Hupfeld & Ruffieux, 2011), measured before randomization (baseline), one week after the last study session (post-treatment), and 4 weeks and 2 months after the last session (follow-up). 5. Scores on the German global self-efficacy expectancy scale (SWE; Jerusalem & Schwarzer, 2003) measured before randomization (baseline), one week after the last session (post-treatment), and 4 weeks and 2 months after the last session ( Follow-up) 6. Scores on the German version of the Emotion Beliefs Questionnaire (EBQ; Grüning et al., 2021), measured before randomization (baseline), one week after the last study therapy (post-treatment), and 4 weeks and 2 months after the last session (follow-up) 7. Scores on the German version of the Rosenberg Self-Esteem Scala (RSES; Collani & Herzberg, 2003), measured before randomization (baseline), one week after the last study therapy (post-treatment), and 4 weeks and 2 months after the last session (follow-up) 8. Scores on the German patient satisfaction questionnaire adapted for the study (ZUF-8; Schmidt et al., 1989), measured one week after the last study therapy session (post-treatment) 9. Core Beliefs about the self, other people and the world, captured by an interview in baseline session, rating (0-100) of the belief that the core belief is true; measured before randomization (baseline), just before each of the three therapy sessions, one week after the last session (post-treatment), and 4 weeks and 2 months after the last session (follow-up) 10. Rating of emotions associated with memories assessed in the baseline session in terms of strength and vividness (0-100), measured before randomization (baseline), just prior to each of the three sessions, one week after the last study therapy session (post-treatment ), and 4 weeks and 2 months after the last session (follow-up)

Study Design

Purpose:
Treatment
Allocation:
Randomized controlled study
Control:
  • Active control (effective treatment of control group)
Phase:
IV
Study type:
Interventional
Mechanism of allocation concealment:
No Entry
Blinding:
Yes
Assignment:
Parallel
Sequence generation:
No Entry
Who is blinded:
  • Patient/subject

Recruitment

Recruitment Status:
Recruiting ongoing
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Germany
Number of study centers:
Monocenter study
Recruitment location(s):
  • Doctor's practice Institut für Psychologie, Freiburg

Recruitment period and number of participants

Planned study start date:
2023-04-10
Actual study start date:
2023-04-27
Planned study completion date:
2025-03-31
Actual Study Completion Date:
No Entry
Target Sample Size:
60
Final Sample Size:
No Entry

Inclusion Criteria

Sex:
All
Minimum Age:
18 Years
Maximum Age:
no maximum age
Additional Inclusion Criteria:
Diagnosis of major depressive disorder or persistend depressive disorder to DSM-V, sufficient proficiency of German language to complete questionnaires

Exclusion Criteria

high risk of suicidality

Addresses

Primary Sponsor

Address:
Institut für Psychologie - Abteilung für klinische Psychologie und Psychotherapie
Fritz Renner
Engelbergerstraße 41
79106 Freiburg
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
Institut für Psychologie - Abteilung für Psychologie und Psychotherapie
Fritz Renner
Engelbergerstraße 41
79106 Freiburg
Germany
Telephone:
00497612033047
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Contact for Public Queries

Address:
Institut für Psychologie - Abteilung für Psychologie und Psychotherapie
Fritz Renner
Engelbergerstraße 41
79106 Freiburg
Germany
Telephone:
00497612033047
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Principal Investigator

Address:
Institut für Psychologie - Abteilung für Psychologie und Psychotherapie
Fritz Renner
Engelbergerstraße 41
79106 Freiburg
Germany
Telephone:
00497612033047
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Sources of Monetary or Material Support

Private sponsorship (foundations, study societies, etc.)

Address:
Alexander von Humboldt-Stiftung (Sofja Kovalevskaja Preis)
53173 Bonn
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Ethics Committee

Address Ethics Committee

Address:
Ethik-Kommission der Albert-Ludwigs-Universität Freiburg
Engelberger Str. 21
79106 Freiburg
Germany
Telephone:
+49-761-27072600
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.uniklinik-freiburg.de/ethikkommission.html

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2022-12-17
Ethics committee number:
22-1518-S2
Vote of the Ethics Committee:
Approved
Date of the vote:
2023-02-27

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
UTN (Universal Trial Number):
No Entry
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
Yes
IPD Sharing Plan:
Available data: Individual participant data; Data shared: Individual participant data that underlie the results reported in the article, after deidentification (text, tables, figures, appendices), other documents available: study protocol, when will data be available (start and end dates): Immediately following article publication, no end date; with whom: anyone who wishes to access the data; for what types of analyses: any purpose.

Study protocol and other study documents

Study protocols:
No Entry
Study abstract:
No Entry
Other study documents:
No Entry
Background literature:
No Entry
Related DRKS studies:
No Entry

Publication of study results

Planned publication:
No Entry
Publikationen/Studienergebnisse:
No Entry
Date of first publication of study results:
No Entry
DRKS entry published for the first time with results:
No Entry

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry